NCT06790498View on ClinicalTrials.gov

Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product

Enrolling by invitationOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

May 31, 2030

Study Completion Date

August 31, 2030

Conditions
Diabetic Kidney DiseaseChronic Kidney Disease
Interventions
BIOLOGICAL

Renal Autologous Cell Therapy (REACT)

No interventions in this trial

Trial Locations (1)

83642

Boise Kidney & Hypertension Institute, Meridian

Sponsors

Lead Sponsor

Prokidney
All Listed Sponsors
lead

Prokidney

INDUSTRY